Improving Quality of Life for Transplant Recipients: AST’s Immunotherapy Medication Survey
- Logistique
- Virtuel
- Durée prévue de l’engagement
- Date limite de candidature
- Type d’organe
- Type d’occasion
- Research Participant
- Thème
The American Society of Transplantation (AST) has developed a survey to address unmet needs with immunosuppression medications for transplant recipients. The survey focuses on transplant recipients’ experiences with anti-rejection medications and aims to improve patient-reported outcomes, including health-related quality of life and side effects.
Participation in this survey will make a difference in improving the post-transplant experience for patients. By gathering valuable insights, AST aim to advocate for safer outcomes and encourage investment in therapeutics that address the overall well-being of transplant recipients.
They believe in finding solutions that minimize the challenges and side effects of long-term immunosuppression while also promoting treatment adherence and improving transplant survival rates. Your input will help them understand if there are better ways to measure the effectiveness of these treatments in clinical trials.
Expérience requise
- If you are a transplant recipient and an adult, please fill out this survey yourself.
- If you are an adult parent or guardian of a transplant recipient that is a minor, we recommend you choose the answer that best describes your child or shows how your child usually feels.
- If you are a minor, you cannot complete this survey on your own.
Rôles potentiels pour les partenaires PFD
Remboursement
Complete the survey here: AST Survey (alchemer.com).
This survey asks about transplant recipient's experiences with anti-rejection medications. This survey is completely anonymous, so please be open and honest in your responses. There is no way to link your responses back to you. This survey is expected to take you 10 to 20 minutes to complete.